These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30416604)

  • 1. C
    Skivka LM; Prylutska SV; Rudyk MP; Khranovska NM; Opeida IV; Hurmach VV; Prylutskyy YI; Sukhodub LF; Ritter U
    Cancer Nanotechnol; 2018; 9(1):8. PubMed ID: 30416604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C
    Hurmach Y; Rudyk M; Prylutska S; Hurmach V; Prylutskyy YI; Ritter U; Scharff P; Skivka L
    Mol Pharm; 2020 Sep; 17(9):3622-3632. PubMed ID: 32673486
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts.
    Liao F; Saitoh Y; Miwa N
    Oncol Res; 2011; 19(5):203-16. PubMed ID: 21542456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
    Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
    Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal.
    Zhang Q; Yang W; Man N; Zheng F; Shen Y; Sun K; Li Y; Wen LP
    Autophagy; 2009 Nov; 5(8):1107-17. PubMed ID: 19786831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation with C
    Grebinyk A; Prylutska S; Grebinyk S; Prylutskyy Y; Ritter U; Matyshevska O; Dandekar T; Frohme M
    Nanoscale Res Lett; 2019 Feb; 14(1):61. PubMed ID: 30788638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C
    Grebinyk A; Grebinyk S; Prylutska S; Ritter U; Matyshevska O; Dandekar T; Frohme M
    Free Radic Biol Med; 2018 Aug; 124():319-327. PubMed ID: 29940354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
    Isakovic A; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Mirkovic M; Dramicanin M; Harhaji L; Raicevic N; Nikolic Z; Trajkovic V
    Toxicol Sci; 2006 May; 91(1):173-83. PubMed ID: 16476688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic reactive oxygen generation.
    Scharff P; Ritter U; Matyshevska OP; Prylutska SV; Grynyuk II; Golub AA; Prylutskyy YI; Burlaka AP
    Tumori; 2008; 94(2):278-83. PubMed ID: 18564617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fullerene-C60 derivatives prevent UV-irradiation/ TiO2-induced cytotoxicity on keratinocytes and 3D-skin tissues through antioxidant actions.
    Kato S; Aoshima H; Saitoh Y; Miwa N
    J Nanosci Nanotechnol; 2014 May; 14(5):3285-91. PubMed ID: 24734542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo, in vitro and in silico anticancer investigation of fullerene C
    Beyaz S; Aslan A; Gok O; Uslu H; Agca CA; Ozercan IH
    Life Sci; 2022 Feb; 291():120281. PubMed ID: 34982963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.
    Panchuk RR; Prylutska SV; Chumakl VV; Skorokhyd NR; Lehka LV; Evstigneev MP; Prylutskyy YI; Berger W; Heffeter P; Scharff P; Ritter U; Stoika RS
    J Biomed Nanotechnol; 2015 Jul; 11(7):1139-52. PubMed ID: 26307837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nanoconjugate of Landomycin A with C
    Bilobrov V; Sokolova V; Prylutska S; Panchuk R; Litsis O; Osetskyi V; Evstigneev M; Prylutskyy Y; Epple M; Ritter U; Rohr J
    Cell Mol Bioeng; 2019 Feb; 12(1):41-51. PubMed ID: 31719898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fullerene C60 Protects Against Intestinal Injury from Deoxynivalenol Toxicity by Improving Antioxidant Capacity.
    Liao S; Liu G; Tan B; Qi M; Li J; Li X; Zhu C; Huang J; Yin Y; Tang Y
    Life (Basel); 2021 May; 11(6):. PubMed ID: 34071941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fullerene C
    Rondags A; Yuen WY; Jonkman MF; Horváth B
    Exp Dermatol; 2017 Mar; 26(3):220-224. PubMed ID: 27541937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative computational study of interaction of C60-fullerene and tris-malonyl-C60-fullerene isomers with lipid bilayer: relation to their antioxidant effect.
    Bozdaganyan ME; Orekhov PS; Shaytan AK; Shaitan KV
    PLoS One; 2014; 9(7):e102487. PubMed ID: 25019215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects and hematotoxicity of C
    Prylutska SV; Lynchak OV; Kostjukov VV; Evstigneev MP; Remeniak OV; Rybalchenko VK; Prylutskyy YI; Ritter U; Scharff P
    Exp Oncol; 2019 Jun; 41(2):106-111. PubMed ID: 31262160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60).
    Markovic Z; Trajkovic V
    Biomaterials; 2008 Sep; 29(26):3561-73. PubMed ID: 18534675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pristine C
    Demir E; Nedzvetsky VS; Ağca CA; Kirici M
    Neurochem Res; 2020 Oct; 45(10):2385-2397. PubMed ID: 32712876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cisplatin-induced reactive oxygen species production by fullerene C(60) in normal and transformed lymphoid cells.
    Franskevych DV; Grynyuk II; Prylutska SV; Matyshevs ka OP
    Ukr Biochem J; 2016; 88(1):44-50. PubMed ID: 29227077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.